Tungstate reduces the expression of gluconeogenic enzymes in STZ rats

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Nocito, Laura ^a,b,c   Zafra, Delia ^a,b   Calbó, Joaquim ^a,b   Domínguez, Jorge ^a,b   Guinovart, Joan J ^a,b,c  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DRINKING WATER; ENZYME; GLUCOSE 6 PHOSPHATASE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHOTRANSFERASE; PROTEIN C FOS; PROTEIN C JUN; PROTEIN KINASE B; PROTEIN P90; TRANSCRIPTION FACTOR; TUNGSTATE SODIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; DISEASE CONTROL; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME REGULATION; GLUCONEOGENESIS; IN VIVO STUDY; LIVER CELL; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; TRANSCRIPTION REGULATION; TREATMENT DURATION; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; GLUCONEOGENESIS; GLUCOSE; GLYCOGEN SYNTHASE; HEPATOCYTES; LIVER; MALE; PHOSPHORYLATION; RATS; RATS, WISTAR; STREPTOZOCIN; TUNGSTEN COMPOUNDS;

ANIMALIA; RATTUS;

EID: 84864674789     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042305     Document Type: Article

References (45)

1. Barbera A, Rodriguez-Gil JE, Guinovart JJ, (1994) Insulin-like actions of tungstate in diabetic rats. Normalization of hepatic glucose metabolism. J Biol Chem 269: 20047-20053.
2. Barbera A, Gomis RR, Prats N, Rodriguez-Gil JE, Domingo M, et al. (2001) Tungstate is an effective antidiabetic agent in streptozotocin-induced diabetic rats: a long-term study. Diabetologia 44: 507-513.
3. Giron MD, Caballero JJ, Vargas AM, Suarez MD, Guinovart JJ, et al. (2003) Modulation of glucose transporters in rat diaphragm by sodium tungstate. FEBS Lett 542: 84-88.
4. Giron MD, Sevillano N, Vargas AM, Dominguez J, Guinovart JJ, et al. (2008) The glucose-lowering agent sodium tungstate increases the levels and translocation of GLUT4 in L6 myotubes through a mechanism associated with ERK1/2 and MEF2D. Diabetologia 51: 1285-1295.
5. Miro-Queralt M, Guinovart JJ, Planas JM, (2008) Sodium tungstate decreases sucrase and Na+/D-glucose cotransporter in the jejunum of diabetic rats. Am J Physiol Gastrointest Liver Physiol 295: G479-484.
6. Claret M, Corominola H, Canals I, Saura J, Barcelo-Batllori S, et al. (2005) Tungstate decreases weight gain and adiposity in obese rats through increased thermogenesis and lipid oxidation. Endocrinology 146: 4362-4369.
7. Amigo-Correig M, Barcelo-Batllori S, Piquer S, Soty M, Pujadas G, et al. (2011) Sodium tungstate regulates food intake and body weight through activation of the hypothalamic leptin pathway. Diabetes Obes Metab 13: 235-242.
8. Dominguez JE, Munoz MC, Zafra D, Sanchez-Perez I, Baque S, et al. (2003) The antidiabetic agent sodium tungstate activates glycogen synthesis through an insulin receptor-independent pathway. J Biol Chem 278: 42785-42794.
9. Thomas JA, Schlender KK, Larner J, (1968) A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose. Anal Biochem 25: 486-499.
10. Chan TM, Exton JH, (1976) A rapid method for the determination of glycogen content and radioactivity in small quantities of tissue or isolated hepatocytes. Anal Biochem 71: 96-105.
11. Massague J, Guinovart JJ, (1977) Insulin control of rat hepatocyte glycogen synthase and phosphorylase in the absence of glucose. FEBS Lett 82: 317-320.
12. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, et al. (2001) Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413: 131-138.
13. Ballester J, Dominguez J, Munoz MC, Sensat M, Rigau T, et al. (2005) Tungstate treatment improves Leydig cell function in streptozotocin-diabetic rats. J Androl 26: 706-715.
14. Morton S, Davis RJ, McLaren A, Cohen P, (2003) A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J 22: 3876-3886.
15. Murphy LO, Smith S, Chen RH, Fingar DC, Blenis J, (2002) Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol 4: 556-564.
16. Gurney AL, Park EA, Giralt M, Liu J, Hanson RW, (1992) Opposing actions of Fos and Jun on transcription of the phosphoenolpyruvate carboxykinase (GTP) gene. Dominant negative regulation by Fos. J Biol Chem 267: 18133-18139.
17. Cheng Z, White MF, (2011) Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models. Antioxid Redox Signal 14: 649-661.
18. Gross DN, van den Heuvel AP, Birnbaum MJ, (2008) The role of FoxO in the regulation of metabolism. Oncogene 27: 2320-2336.
19. Rhee J, Inoue Y, Yoon JC, Puigserver P, Fan M, et al. (2003) Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc Natl Acad Sci U S A 100: 4012-4017.
20. Oyadomari S, Matsuno F, Chowdhury S, Kimura T, Iwase K, et al. (2000) The gene for hepatocyte nuclear factor (HNF)-4alpha is activated by glucocorticoids and glucagon, and repressed by insulin in rat liver. FEBS Lett 478: 141-146.
21. Puigserver P, (2005) Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha. Int J Obes (Lond) 29 Suppl 1: S5-9.
22. Jones CG, Hothi SK, Titheradge MA, (1993) Effect of dexamethasone on gluconeogenesis, pyruvate kinase, pyruvate carboxylase and pyruvate dehydrogenase flux in isolated hepatocytes. Biochem J 289 (Pt 3): 821-828.
23. Agius L, Chowdhury MH, Alberti KG, (1986) Regulation of ketogenesis, gluconeogenesis and the mitochondrial redox state by dexamethasone in hepatocyte monolayer cultures. Biochem J 239: 593-601.
24. Munoz MC, Barbera A, Dominguez J, Fernandez-Alvarez J, Gomis R, et al. (2001) Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats. Diabetes 50: 131-138.
25. Mage M, Pecher C, Neau E, Cellier E, Dos Reiss ML, et al. (2002) Induction of B1 receptors in streptozotocin diabetic rats: possible involvement in the control of hyperglycemia-induced glomerular Erk 1 and 2 phosphorylation. Can J Physiol Pharmacol 80: 328-333.
26. Thirone AC, Scarlett JA, Gasparetti AL, Araujo EP, Lima MH, et al. (2002) Modulation of growth hormone signal transduction in kidneys of streptozotocin-induced diabetic animals: effect of a growth hormone receptor antagonist. Diabetes 51: 2270-2281.
27. Naito Z, Takashi E, Xu G, Ishiwata T, Teduka K, et al. (2003) Different influences of hyperglycemic duration on phosphorylated extracellular signal-regulated kinase 1/2 in rat heart. Exp Mol Pathol 74: 23-32.
28. Ekladous D, Mehdi MZ, Costa M, Srivastava AK, Chiasson JL, et al. (2008) Tissue- and fibre-specific modifications of insulin-signalling molecules in cardiac and skeletal muscle of diabetic rats. Clin Exp Pharmacol Physiol 35: 971-978.
29. Yang S, Lin HZ, Hwang J, Chacko VP, Diehl AM, (2001) Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res 61: 5016-5023.
30. Cohen P, Frame S, (2001) The renaissance of GSK3. Nat Rev Mol Cell Biol 2: 769-776.
31. Sutherland C, Cohen P, (1994) The alpha-isoform of glycogen synthase kinase-3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase-activated protein kinase-1 in vitro. FEBS Lett 338: 37-42.
32. Sutherland C, Leighton IA, Cohen P, (1993) Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 296 (Pt 1): 15-19.
33. Embi N, Rylatt DB, Cohen P, (1980) Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem 107: 519-527.
34. Barbera A, Munoz MC, Guinovart JJ, (1998) Effects of tungstate administration to Zucker Diabetic Fatty rats. Diabetologia 41: 915.
35. Gille H, Sharrocks AD, Shaw PE, (1992) Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 358: 414-417.
36. Garcia CA, Wang H, Benakanakere MR, Barrett E, Kinane DF, et al. (2009) c-jun controls the ability of IL-12 to induce IL-10 production from human memory CD4+ T cells. J Immunol 183: 4475-4482.
37. Bjorbaek C, Zhao Y, Moller DE, (1995) Divergent functional roles for p90rsk kinase domains. J Biol Chem 270: 18848-18852.
38. Frodin M, Gammeltoft S, (1999) Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 151: 65-77.
39. He Q, Harding P, LaPointe MC, (2010) PKA, Rap1, ERK1/2, and p90RSK mediate PGE2 and EP4 signaling in neonatal ventricular myocytes. Am J Physiol Heart Circ Physiol 298: H136-143.
40. Zhang W, Patil S, Chauhan B, Guo S, Powell DR, et al. (2006) FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J Biol Chem 281: 10105-10117.
41. Fernandez-Alvarez J, Barbera A, Nadal B, Barcelo-Batllori S, Piquer S, et al. (2004) Stable and functional regeneration of pancreatic beta-cell population in nSTZ-rats treated with tungstate. Diabetologia 47: 470-477.
42. Siddle K, (2011) Signalling by insulin and IGF receptors: supporting acts and new players. J Mol Endocrinol 47: R1-10.
43. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, et al. (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15: 6541-6551.
44. Burgering BM, Coffer PJ, (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599-602.
45. Whiteman EL, Cho H, Birnbaum MJ, (2002) Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab 13: 444-451.